Top Markets
#1 MowCat MowCat +366.96%
#2 龙虾 (Lobster) 龙虾 (Lobster) +68.62%
#3 SODAX SODAX +47.33%
#4 Cortex Cortex +33.10%
#5 MANTRA MANTRA +24.62%
#6 DexNet DexNet +23.19%
#7 OpenEden OpenEden +18.34%
#8 Akedo Akedo +17.22%
#9 BNB Attestation Service BNB Attestation Service +16.69%
#10 wojak wojak +14.96%
Coin of the day
MowCat MowCat
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Maze Therapeutics, Inc. Maze Therapeutics, Inc.

Maze Therapeutics, Inc.

MAZE
Classificação em ações #7497
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops... Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor that is in phase II ready clinical trial for the treatment of phenylketonuria and chronic kidney disease. The company also develops MZE001, an investigational oral small molecule inhibitor of muscle-specific glycogen synthase clinical program for the treatment of Pompe disease. It has a license agreement with Trace Neuroscience, Inc. to discovery research program targets UNC13A; the Shionogi & Co., Ltd to research, develop, manufacture, and commercialize MZE001; and Neurocrine Biosciences, Inc. to discover research program that targets ATXN2. The company was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
Preço da ação
$28.25
Última sincronização: 2026-08-27
Valor de mercado
$1.56B
Variação (1 dia)
-4.50%
Variação (1 ano)
97.97%
País
US
Negociar Maze Therapeutics, Inc. (MAZE)

Categoria

Healthcare
Histórico de dividendos de Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (símbolo da ação: MAZE) realizou um total de 0 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: 0.00
Rendimento de dividendos (TTM): 0
Pagamentos de dividendos de Maze Therapeutics, Inc. (MAZE) de 2026 a 2026
Pagamentos anuais de dividendos
Ano Dividendo (ajustado para desdobramentos) Alterar
Não há dados suficientes para as datas fornecidas.
Lista de todos os pagamentos de dividendos
Ano Dividendo Alterar
Não há dados suficientes para as datas fornecidas.
Dividendos de empresas semelhantes ou concorrentes
Empresa Número de pagamentos de dividendos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH